Evidence map›Paper›PMID 23092923›Full record

ArticleInvestigative ophthalmology & visual science2012

From blood islands to blood vessels: morphologic observations and expression of key molecules during hyaloid vascular system development.

D Scott McLeod, Takuya Hasegawa, Takayuki Baba, Rhonda Grebe, Ines Galtier d'Auriac, Carol Merges, Malia Edwards, Gerard A Lutty

Open access · bronzeAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Resident immune cells of the avascular lens: Mediators of the injury and fibrotic response of the lens.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  4. Article
  5. An immune response to the avascular lens following wounding of the cornea involves ciliary zonule fibrils.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  6. Microglia in the developing retina.Neural development · 2019
    Review
  7. Article
  8. Article
  9. Building Blood Vessels with Vascular Progenitor Cells.Trends in molecular medicine · 2018
    Review
  10. A Modular Strategy to Engineer Complex Tissues and Organs.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2018
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

D Scott McLeodWilmer Eye Institute, Baltimore, Maryland 21784, USA.
Takuya Hasegawa
Takayuki Baba
Rhonda Grebe
Ines Galtier d'Auriac
Carol Merges
Malia Edwards
Gerard A Lutty
Johns Hopkins University · USJohns Hopkins Hospital · USUniversity of Baltimore · US

Funding

Wilmer Core Grant for Vision ResearchP30EY001765 · NEI · JOHNS HOPKINS UNIVERSITY · PI Jiang Qian · 1985 to 2026
$22.1M
Vasculogenesis and hyperoxia in the developing retina.R01EY009357 · NEI · JOHNS HOPKINS UNIVERSITY · PI LUTTY, GERARD ANTHONY · 1993 to 2014
$5.3M
NEI NIH HHS EY-01765NEI NIH HHS P30 EY001765NEI NIH HHS R01 EY009357NEI NIH HHS R01-EY09357
6 · The paper itself

Abstract

purposeThe mode of development of the human hyaloid vascular system (HVS) remains unclear. Early studies suggested that these blood vessels formed by vasculogenesis, while the current concept seems to favor angiogenesis as the mode of development. We examined embryonic and fetal human HVS using a variety of techniques to gain new insights into formation of this vasculature.

methodsEmbryonic and fetal human eyes from 5.5 to 12 weeks gestation (WG) were prepared for immunohistochemical analysis or for light and electron microscopy. Immunolabeling of sections with a panel of antibodies directed at growth factors, transcription factors, and hematopoietic stem cell markers was employed.

resultsLight microscopic examination revealed free blood islands (BI) in the embryonic vitreous cavity (5.5-7 WG). Giemsa stain revealed that BI were aggregates of mesenchymal cells and primitive nucleated erythroblasts. Free cells were also observed. Immunolabeling demonstrated that BI were composed of mesenchymal cells that expressed hemangioblast markers (CD31, CD34, C-kit, CXCR4, Runx1, and VEGFR2), erythroblasts that expressed embryonic hemoglobin (Hb-ε), and cells that expressed both. Few cells were proliferating as determined by lack of Ki67 antigen. As development progressed (12 WG), blood vessels became more mature structurally with pericyte investment and basement membrane formation. Concomitantly, Hb-ε and CXCR4 expression was down-regulated and von Willebrand factor expression was increased with the formation of Weibel-Palade bodies.

conclusionsOur results support the view that the human HVS, like the choriocapillaris, develops by hemo-vasculogenesis, the process by which vasculogenesis, erythropoiesis, and hematopoiesis occur simultaneously from common precursors, hemangioblasts.

Indexed as

Antigens, CD34BiomarkersEndothelium, VascularErythroblastsFetal HemoglobinFluorescent Antibody Technique, IndirectGestational AgeHumansImmunoenzyme TechniquesLens, CrystallineMesodermMicroscopy, ConfocalMicroscopy, Electron, TransmissionNeovascularization, PhysiologicOphthalmic ArteryPlatelet Endothelial Cell Adhesion Molecule-1Antigens, CD34BiomarkersCXCR4 protein, humanFetal HemoglobinPlatelet Endothelial Cell Adhesion Molecule-1Proto-Oncogene Proteins c-kitReceptors, CXCR4Vascular Endothelial Growth Factor Receptor-2

Identifiers

PMID23092923
PMCPMC3513274
OpenAlexW1997672256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.